Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer Statistics. CA Cancer J Clin, 68, 7–30. https://doi.org/10.3322/caac.21442.

Article  PubMed  Google Scholar 

Harris, W. P., Mostaghel, E. A., Nelson, P. S., & Montgomery, B. (2009). Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol, 6, 76–85. https://doi.org/10.1038/ncpuro1296.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brighi, N., Conteduca, V., & Lolli, C., et al. (2021). The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives. Crit Rev Oncol Hematol, 157, 103199. https://doi.org/10.1016/j.critrevonc.2020.103199.

Article  PubMed  Google Scholar 

Baldin, V., Lukas, J., & Marcote, M. J., et al. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev, 7, 812–821. https://doi.org/10.1101/gad.7.5.812.

Article  CAS  PubMed  Google Scholar 

Massagué, J. (2004). G1 cell-cycle control and cancer. Nature, 432, 298–306. https://doi.org/10.1038/nature03094.

Article  CAS  PubMed  Google Scholar 

Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022). Cell cycle control in cancer. Nat Rev Mol Cell Biol, 23, 74–88. https://doi.org/10.1038/s41580-021-00404-3.

Article  CAS  PubMed  Google Scholar 

Fu, M., Wang, C., & Li, Z., et al. (2004). Minireview: Cyclin D1: normal and abnormal functions. Endocrinology, 145, 5439–5447. https://doi.org/10.1210/en.2004-0959.

Article  CAS  PubMed  Google Scholar 

Ju, X., Casimiro, M. C., & Gormley, M., et al. (2014). Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint. Cancer Res, 74, 508–519. https://doi.org/10.1158/0008-5472.CAN-13-1313.

Article  CAS  PubMed  Google Scholar 

Dulińska-Litewka, J., Felkle, D., & Dykas, K., et al. (2022). The role of cyclins in the development and progression of prostate cancer. Biomed Pharmacother Biomed Pharmacother, 155, 113742 https://doi.org/10.1016/j.biopha.2022.113742.

Article  CAS  PubMed  Google Scholar 

Zhong, W., Qin, G., & Dai, Q., et al. (2012). SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer, 12, 248 https://doi.org/10.1186/1471-2407-12-248.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ouyang, X., Jessen, W. J., & Al-Ahmadie, H., et al. (2008). Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res, 68, 2132–2144. https://doi.org/10.1158/0008-5472.CAN-07-6055.

Article  CAS  PubMed  Google Scholar 

Wegner, M. (2010). All purpose Sox: The many roles of Sox proteins in gene expression. Int J Biochem Cell Biol, 42, 381–390. https://doi.org/10.1016/j.biocel.2009.07.006.

Article  CAS  PubMed  Google Scholar 

Kondoh, H., & Kamachi, Y. (2010). SOX-partner code for cell specification: Regulatory target selection and underlying molecular mechanisms. Int J Biochem Cell Biol, 42, 391–399. https://doi.org/10.1016/j.biocel.2009.09.003.

Article  CAS  PubMed  Google Scholar 

She, Z.-Y., & Yang, W.-X. (2015). SOX family transcription factors involved in diverse cellular events during development. Eur J Cell Biol, 94, 547–563. https://doi.org/10.1016/j.ejcb.2015.08.002.

Article  CAS  PubMed  Google Scholar 

Parsons, E. C., Hoffmann, R., & Baillie, G. S. (2023). Revisiting the roles of cAMP signalling in the progression of prostate cancer. Biochem J, 480, 1599–1614. https://doi.org/10.1042/BCJ20230297.

Article  CAS  PubMed  Google Scholar 

Huang, W., Zhou, X., Lefebvre, V., & de Crombrugghe, B. (2000). Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9’s ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol, 20, 4149–4158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, W., Chung, U. I., Kronenberg, H. M., & de Crombrugghe, B. (2001). The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA, 98, 160–165. https://doi.org/10.1073/pnas.98.1.160.

Article  CAS  PubMed  Google Scholar 

Gioeli, D., Mandell, J. W., & Petroni, G. R., et al. (1999). Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res, 59, 279–284.

CAS  PubMed  Google Scholar 

Maroni, P. D., Koul, S., Meacham, R. B., & Koul, H. K. (2004). Mitogen Activated Protein kinase signal transduction pathways in the prostate. Cell Commun Signal CCS, 2, 5. https://doi.org/10.1186/1478-811X-2-5.

Article  CAS  PubMed  Google Scholar 

Mukherjee, R., Bartlett, J. M. S., & Krishna, N. S., et al. (2005). Raf-1 expression may influence progression to androgen insensitive prostate cancer. Prostate, 64, 101–107. https://doi.org/10.1002/pros.20211.

Article  CAS  PubMed  Google Scholar 

Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem, 270, 16483–16486. https://doi.org/10.1074/jbc.270.28.16483.

Article  CAS  PubMed  Google Scholar 

Chalmers, C. J., Gilley, R., & March, H. N., et al. (2007). The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal, 19, 695–704. https://doi.org/10.1016/j.cellsig.2006.09.001.

Article  CAS  PubMed  Google Scholar 

Ghouili, F., Roumaud, P., & Martin, L. J. (2018). Gja1 expression is regulated by cooperation between SOX8/SOX9 and cJUN transcription factors in TM4 and 15P-1 Sertoli cell lines. Mol Reprod Dev, 85, 875–886. https://doi.org/10.1002/mrd.23049.

Article  CAS  PubMed  Google Scholar 

O’Shea, E. K., Rutkowski, R., & Kim, P. S. (1992). Mechanism of specificity in the Fos-Jun oncoprotein heterodimer. Cell, 68, 699–708. https://doi.org/10.1016/0092-8674(92)90145-3.

Article  PubMed  Google Scholar 

Kajanne, R., Miettinen, P., Tenhunen, M., & Leppä, S. (2009). Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells. Int J Oncol, 35, 1175–1182. https://doi.org/10.3892/ijo_00000434.

Article  CAS  PubMed  Google Scholar 

Nguyen, H. T., Najih, M., & Martin, L. J. (2021). The AP-1 family of transcription factors are important regulators of gene expression within Leydig cells. Endocrine, 74, 498–507. https://doi.org/10.1007/s12020-021-02888-7.

Article  CAS  PubMed  Google Scholar 

Sato, N., Sadar, M. D., & Bruchovsky, N., et al. (1997). Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem, 272, 17485–17494. https://doi.org/10.1074/jbc.272.28.17485.

Article  CAS  PubMed  Google Scholar 

Edwards, J., Krishna, N. S., Mukherjee, R., & Bartlett, J. M. S. (2004). The role of c-Jun and c-Fos expression in androgen-independent prostate cancer. J Pathol, 204, 153–158. https://doi.org/10.1002/path.1605.

Article  CAS  PubMed  Google Scholar 

Tyman, J. H., & Kiong, L. S. (1978). Long chain phenols: Part XI. Composition of natural cashew nutshell liquid (Anacardium occidentale) from various sources. Lipids, 13, 525–532.